Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Utility of Acarbose in Ischemic Heart Disease With Abnormal Glucose Regulation
NCT00858676Phase 4Unknown
- Start
- Apr 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acarbose in type 2 diabetes mellitus (T2DM), impaired glucose tolerance (IGT). Status: unknown.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00858676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00858676.